Alzheimer's Plasma Extension
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Aisen, MD
University of Southern California (USC) Alzheimer's Therapeutic Research Institute (ATRI)
Study Director - Reisa Sperling, MD
Brigham and Women's Hospital and Massachusetts General Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Banner Alzheimer'S Institute
Phoenix, Arizona, United States
- Banner Sun Health Research Institute
Sun City, Arizona, United States
- University of California, Irvine
Irvine, California, United States
- University of Southern California
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- Sharp Neurocognitive Research Center
San Diego, California, United States
- University of California, San Francisco
San Francisco, California, United States
- University of California, Davis
Walnut Creek, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Howard University
Washington D.C., District of Columbia, United States
- Brain Matters Research
Delray Beach, Florida, United States
- Mayo Clinic, Jacksonville
Jacksonville, Florida, United States
- K2 Medical Research - the Villages
Lady Lake, Florida, United States
- K2 Medical Research, Llc
Maitland, Florida, United States
- Gonzalez Md & Aswad Md Health Services
Miami, Florida, United States
- Wien Center for Clinical Research
Miami Beach, Florida, United States
- Charter Research
Orlando, Florida, United States
- University of South Florida - Health Byrd Alzheimer Institute
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Kansas
Fairway, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Boston University
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Headlands Eastern Ma Llc
Plymouth, Massachusetts, United States
- University of Michigan, Ann Arbor
Ann Arbor, Michigan, United States
- Mayo Clinic, Rochester
Rochester, Minnesota, United States
- Washington University, St. Louis
St Louis, Missouri, United States
- Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas
Las Vegas, Nevada, United States
- Columbia University
New York, New York, United States
- Mount Sinai School of Medicine
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Case Western Reserve University
Beachwood, Ohio, United States
- Cleveland Clinic Lou Ruvo Center for Brain Health, Ohio
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Sept 2023
- Primary completion
- 30 Jun 2028
- Completion
- 30 Jun 2028
- Last update posted
- 10 Jun 2025
- Registered enrollment
- 1,000
- Registry id
- NCT06416072
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.